세계의 의약품 검사기 시장, 시장 규모, 점유율, 동향 : 구성요소별, 유형별, 포장 유형별, 제형별 - 예측(-2029년)

The pharmaceutical inspection machines market is projected to reach USD 1.4 billion by 2029 from USD 0.9 billion in 2024, at a CAGR of 7.6% during the forecast period.

"The Vision Inspection System segment holds dominant share in the pharmaceutical inspection machines market."

Based on the component, the pharmaceutical inspection machines market is divided into inspection systems and software. The inspection systems is further segmented into vision inspection systems, X-ray inspection systems, leak detection systems, metal detectors, combination systems, checkweighers, and other inspection systems. The vision inspection systems dominated the segment owing to various factors such as increasing demand for high-speed and accurate defect detection in pharmaceutical manufacturing and launch of technologically advanced vision inspection systems with AI & machine learning.

"Syringes pharmaceutical inspection machines market is likely to grow at faster pace."

Based on the packaging type, the pharmaceutical inspection machines market is divided into syringes, blister, ampoules & vials, bottles, and other packaging types. Syringe segment in the pharmaceutical inspection machines market grows at a faster pace in 2023. The significant growth of syringe segment in the packaging type segment is due to increasing adoption of inspection machinery for assessing pre-filled syringes, focus on ensuring product integrity and minimizing risks associated with contamination or defects, and advancements in inspection technology, such as enhanced capabilities in detecting minute abnormalities or ensuring proper labeling.

"The fully automated inspection machines dominated the type segments."

Based on type, the pharmaceutical inspection machines market is segmented into, semi-automated inspection systems, manual systems, and fully automated inspection systems. The fully automated inspection systems dominated the type segment however semi-automated inspection systems is anticipated to grow at significant CAGR during the forecast period. Factors like increased detection rates, enhanced throughput rates and precise inspection capabilities for the fully automated systems are likely to drive the segmental growth.

"CROs & CDMOs segment is likely to grow at significant CAGR during the forecast period"

Based on end user, the pharmaceutical inspection machines market is segmented into, pharmaceutical companies, biotechnology companies and CROs & CDMOs. The pharmaceutical company segment dominated the pharmaceutical inspection machines market. CROs & CDMOs segment is anticipated to grow at significant CAGR during the forecast period owing to increased outsourcing of pharmaceutical productions and rise in number of CDMOs across the emerging markets.

"Asia Pacific region estimated to show fastest growth rate."

Geographically, the pharmaceutical inspection machines market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the pharmaceutical inspection machines market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as rising production of generic drugs and the rapid expansion of pharmaceutical and biotechnology sectors in the region. Furthermore, rise in outsourcing trends, and increased focus on quality control is likely drive market expansion in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70%, and Demand Side - 30%
• By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%

List of Companies Profiled in the Report:

• Korber AG (Germany)
• Mettler-Toledo (Switzerland)
• Omron Corporation (Japan)
• Cognex corporation (US)
• Stevanato Group (Italy)
• Antares Vision S.P.A (Italy)
• Syntegon Technology GmbH (Germany)
• Optel Group (Canada)
• Jekson Vision (India),
• ACG (India)
• Brevetti CEA SPA (Italy)
• Roquette Freres (France)
• Tofflon Life Science(China)
• Proditec (France)
• Wipotec Gmbh (Germany)
• CMP Pharma S.R.L (Italy)
• Keyence Corporation (Japan),
• Cassel Messentechnik Gmbh (Germany)
• Thermo Fisher Scientific Inc (US)
• Loma Systems (UK),
• Vitronic Dr.-Ing. Stein Bildverarbeitungssysteme GmbH (Germany)
• Minebea Intec Gmbh (Germany)
• Marchesini Group S.p.A. (Italy)
• N.K.P pharma Pvt Ltd (India)
• Span systems (India)

Research Coverage:

This report provides a detailed picture of the pharmaceutical inspection machines market. It aims at estimating the size and future growth potential of the market across different segments such as components, type, packaging type, formulation, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key Drivers (Increasing use of pharmaceutical inspection machines by pharmaceutical and biotechnology companies, Increasing number of inspection checkpoint mandates, Increasing product recall), restraints (High Initial Investment, Data Security and Privacy Concerns) opportunities (Rising outsourcing of manufacturing operations to emerging economies, Advancement in technologies such as IoT, machine learning, and artificial intelligence), and challenges (Complexities in integrating pharmaceutical inspection machines) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the pharmaceutical inspection machines market.
• Market Development: Comprehensive information about lucrative markets the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical inspection machines market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products offerings of leading players like Korber AG (Germany), Mettler-Toledo (Switzerland), Omron Corporation (Japan), Cognex corporation (US), Stevanato Group (Italy), Antares Vision S.P.A (Italy), Syntegon Technology GmbH (Germany), Optel Group (Canada), Jekson Vision (India), ACG (India), Brevetti CEA SPA (Italy), Roquette Freres (France), Tofflon Life Science (China), Proditec (France), Wipotec Gmbh (Germany) CMP Pharma S.R.L (Italy), Keyence Corporation (Japan), Cassel Messentechnik Gmbh (Germany), Thermo Fisher Scientific Inc (US), Loma Systems (UK), Vitronic Dr.-Ing. Stein Bildverarbeitungssysteme GmbH (Germany), Minebea Intec Gmbh (Germany), Marchesini Group S.p.A. (Italy), N.K.P pharma Pvt Ltd (India) and Span systems (India).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS & EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 SEGMENTS COVERED
  • 1.4.2 REGIONS COVERED
  • 1.4.3 YEARS CONSIDERED
  • 1.4.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
  • 1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Objectives of secondary research
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Objectives of primary research
    • 2.1.2.2 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
  • 2.2.2 SEGMENTAL MARKET SIZE ESTIMATION
• 2.3 GROWTH RATE ASSUMPTIONS
• 2.4 STUDY ASSUMPTIONS
• 2.5 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.6 RISK ANALYSIS
• 2.7 RESEARCH LIMITATIONS
• 2.8 IMPACT OF ECONOMIC RECESSION ON PHARMACEUTICAL INSPECTION MACHINES MARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PHARMACEUTICAL INSPECTION MACHINES MARKET OVERVIEW
• 4.2 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE AND COUNTRY (2023)
• 4.3 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024 VS. 2029
• 4.4 PHARMACEUTICAL INSPECTION MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing use of inspection machines by pharmaceutical and biotechnology companies
    • 5.2.1.2 Rising number of inspection checkpoint mandates
    • 5.2.1.3 Technological advancements and stringent regulatory mandates for high-quality products
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High initial capital expenditure and recurring maintenance costs
    • 5.2.2.2 Increased data security and privacy concerns
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing outsourcing of manufacturing operations to emerging economies
    • 5.2.3.2 Focus on production optimization and high R&D investments
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Complexities in integrating pharmaceutical inspection machines
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Machine vision technology
    • 5.4.1.2 X-ray inspection technology
    • 5.4.1.3 Laser inspection technology
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Advanced sensors and imaging techniques
    • 5.4.2.2 Robotics and automation
    • 5.4.2.3 Artificial intelligence
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE PRICING ANALYSIS FOR INSPECTION MACHINES, BY COMPONENT
  • 5.5.2 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL INSPECTION MACHINES, BY REGION
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 SUPPLY CHAIN ANALYSIS
  • 5.7.1 ROLE IN SUPPLY CHAIN
• 5.8 ECOSYSTEM ANALYSIS
  • 5.8.1 PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS
  • 5.8.2 END USERS
  • 5.8.3 REGULATORY BODIES
• 5.9 PATENT ANALYSIS
  • 5.9.1 METHODOLOGY
  • 5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014-2024
  • 5.9.3 INNOVATION AND PATENT APPLICATION
  • 5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS
• 5.1 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180)
  • 5.10.2 EXPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180)
  • 5.10.3 IMPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190)
  • 5.10.4 EXPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190)
• 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 CDRH REGULATIONS ON PHARMACEUTICAL INSPECTION MACHINES
  • 5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.12.2.1 North America: List of regulatory bodies, government agencies, and other organizations
    • 5.12.2.2 Europe: List of regulatory bodies, government agencies, and other organizations
    • 5.12.2.3 Asia Pacific: List of regulatory bodies, government agencies, and other organizations
    • 5.12.2.4 Rest of the World: List of regulatory bodies, government agencies, and other organizations
• 5.13 INVESTMENT AND FUNDING SCENARIO
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 THREAT OF NEW ENTRANTS
  • 5.14.2 THREAT OF SUBSTITUTES
  • 5.14.3 BARGAINING POWER OF BUYERS
  • 5.14.4 BARGAINING POWER OF SUPPLIERS
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS
  • 5.15.2 KEY BUYING CRITERIA

6 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT

• 6.1 INTRODUCTION
• 6.2 PHARMACEUTICAL INSPECTION SYSTEMS
  • 6.2.1 VISION INSPECTION SYSTEMS
    • 6.2.1.1 Multifunctional vision inspection systems
      • 6.2.1.1.1 Versatility and improved production efficiency to drive segment
    • 6.2.1.2 Specialized vision inspection systems
      • 6.2.1.2.1 Stringent quality standards and better patient well-being to propel segment growth
  • 6.2.2 X-RAY INSPECTION SYSTEMS
    • 6.2.2.1 Increasing demand for precise underfill and overfill inspection to aid market growth
  • 6.2.3 LEAK DETECTION SYSTEMS
    • 6.2.3.1 Rising adoption in pharmaceutical applications to drive market growth
  • 6.2.4 METAL DETECTORS
    • 6.2.4.1 Growing need for metal contaminant detection in food & beverage industry to boost demand
  • 6.2.5 CHECKWEIGHERS
    • 6.2.5.1 Increased focus on reducing waste in manufacturing process to aid market growth
  • 6.2.6 COMBINATION SYSTEMS
    • 6.2.6.1 Technological advancements for ensuring thorough quality assessment and regulatory compliance to drive market
  • 6.2.7 OTHER PHARMACEUTICAL INSPECTION SYSTEMS
• 6.3 PHARMACEUTICAL INSPECTION SOFTWARE
  • 6.3.1 RISING NEED TO IMPROVE INSPECTION EFFICIENCY TO PROPEL ADOPTION

7 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES
  • 7.2.1 SUPERIOR THROUGHPUT RATES AND DEFECT DETECTION ACCURACY IN HIGH-VISCOSITY SUSPENSIONS TO DRIVE MARKET
• 7.3 SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES
  • 7.3.1 SIMULTANEOUS INSPECTION CAPABILITIES WITH HIGH STANDARDS OF PHARMACEUTICAL QUALITY CONTROL TO AID MARKET GROWTH
• 7.4 MANUAL PHARMACEUTICAL INSPECTION MACHINES
  • 7.4.1 COST-EFFECTIVENESS TO AUGMENT SEGMENT GROWTH

8 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE

• 8.1 INTRODUCTION
• 8.2 AMPOULES & VIALS
  • 8.2.1 INCREASING DEMAND FOR VACCINES AND BIOPHARMACEUTICALS TO FUEL MARKET GROWTH
• 8.3 SYRINGES
  • 8.3.1 IMPROVED SAFETY AND INCREASED COMPLIANCE WITH CGMP STANDARDS TO SUPPORT MARKET GROWTH
• 8.4 BOTTLES
  • 8.4.1 RISING DEMAND FOR LIQUID OR SOLID RESIDUE DETECTION TO AUGMENT MARKET GROWTH
• 8.5 BLISTERS
  • 8.5.1 SUPERIOR PRODUCT PROTECTION AND ENHANCED PATIENT COMPLIANCE TO BOOST MARKET GROWTH
• 8.6 OTHER PACKAGING TYPES

9 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION

• 9.1 INTRODUCTION
• 9.2 ORAL FORMULATIONS
  • 9.2.1 TABLETS & CAPSULES
    • 9.2.1.1 Increasing applications in pharmaceutical industry to drive segment
  • 9.2.2 ORAL SOLUTIONS & SUSPENSIONS/SYRUPS
    • 9.2.2.1 Focus on improved product quality and prevention of contamination to fuel segment growth
  • 9.2.3 OTHER ORAL FORMULATIONS
• 9.3 PARENTERAL FORMULATIONS
  • 9.3.1 INCREASED PRODUCTION THROUGHPUT AND REDUCED HUMAN ERRORS TO BOOST SEGMENT GROWTH
• 9.4 OTHER FORMULATIONS

10 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 PHARMACEUTICAL COMPANIES
  • 10.2.1 HIGH PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
• 10.3 BIOTECHNOLOGY COMPANIES
  • 10.3.1 FOCUS ON REDUCING COUNTERFEIT DRUG PRODUCTION AND IMPROVING PRODUCT QUALITY TO SPUR MARKET GROWTH
• 10.4 CROS & CDMOS
  • 10.4.1 LOW MANUFACTURING COSTS AND HIGH-QUALITY MAINTENANCE TO FUEL MARKET GROWTH

11 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 US to dominate North American pharmaceutical inspection machines market during forecast period
  • 11.2.2 CANADA
    • 11.2.2.1 Focus on better healthcare quality and increased patient safety to support market growth
  • 11.2.3 NORTH AMERICA: RECESSION IMPACT
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 High healthcare spending and presence of key pharmaceutical manufacturers to aid market growth
  • 11.3.2 UK
    • 11.3.2.1 Rising demand for personalized medicines and increasing geriatric population to augment market growth
  • 11.3.3 FRANCE
    • 11.3.3.1 Growth in generic drug market and increased pharmaceutical exports to spur adoption
  • 11.3.4 ITALY
    • 11.3.4.1 Favorable government initiatives and increased private investments to drive market
  • 11.3.5 SPAIN
    • 11.3.5.1 Improved healthcare infrastructure and high prevalence of chronic diseases to boost market growth
  • 11.3.6 REST OF EUROPE
  • 11.3.7 EUROPE: RECESSION IMPACT
• 11.4 ASIA PACIFIC
  • 11.4.1 CHINA
    • 11.4.1.1 Increased investment in healthcare infrastructure to propel market growth
  • 11.4.2 JAPAN
    • 11.4.2.1 Well-developed pharmaceutical manufacturing industry and stringent healthcare regulations to drive market
  • 11.4.3 INDIA
    • 11.4.3.1 Growing focus on cost-effective branded drug production to fuel market growth
  • 11.4.4 AUSTRALIA
    • 11.4.4.1 High R&D expenditure and technological advancements to fuel market growth
  • 11.4.5 SOUTH KOREA
    • 11.4.5.1 Attractive medical tourism industry and favorable government policies to propel market growth
  • 11.4.6 REST OF ASIA PACIFIC
  • 11.4.7 ASIA PACIFIC: RECESSION IMPACT
• 11.5 LATIN AMERICA
  • 11.5.1 BRAZIL
    • 11.5.1.1 Increasing geriatric population and rising per capita income to aid market growth
  • 11.5.2 MEXICO
    • 11.5.2.1 Improving healthcare infrastructure and burgeoning pharmaceutical industry to augment market growth
  • 11.5.3 REST OF LATIN AMERICA
  • 11.5.4 LATIN AMERICA: RECESSION IMPACT
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 GCC COUNTRIES
    • 11.6.1.1 Robust economic growth and high public healthcare spending to support market growth
  • 11.6.2 REST OF MIDDLE EAST & AFRICA
  • 11.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET
• 12.3 REVENUE ANALYSIS
• 12.4 MARKET SHARE ANALYSIS
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Component footprint
    • 12.5.5.3 Type footprint
    • 12.5.5.4 Packaging type footprint
    • 12.5.5.5 Region footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 12.7 VALUATION & FINANCIAL METRICS
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 KORBER AG
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Services/Solutions offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 METTLER TOLEDO
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Services/Solutions offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 OMRON CORPORATION
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Services/Solutions offered
    • 13.1.3.3 MnM view
      • 13.1.3.3.1 Key strengths
      • 13.1.3.3.2 Strategic choices
      • 13.1.3.3.3 Weaknesses & competitive threats
  • 13.1.4 COGNEX CORPORATION
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Services/Solutions offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches
      • 13.1.4.3.2 Deals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 STEVANATO GROUP
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Services/Solutions offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Key strengths
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 ANTARES VISION S.P.A
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Services/Solutions offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
  • 13.1.7 OPTEL GROUP
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Services/Solutions offered
  • 13.1.8 SYNTEGON TECHNOLOGY GMBH
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Services/Solutions offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
  • 13.1.9 JEKSON VISION
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Services/Solutions offered
  • 13.1.10 ACG
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Services/Solutions offered
  • 13.1.11 BREVETTI CEA SPA
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Services/Solutions offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
  • 13.1.12 ROQUETTE FRERES
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Services/Solutions offered
  • 13.1.13 TOFFLON LIFE SCIENCE
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Services/Solutions offered
  • 13.1.14 PRODITEC
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products/Services/Solutions offered
  • 13.1.15 WIPOTEC GMBH
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products/Services/Solutions offered
  • 13.1.16 CMP PHARMA S.R.L.
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products/Services/Solutions offered
    • 13.1.16.3 Recent developments
      • 13.1.16.3.1 Expansions
• 13.2 OTHER PLAYERS
  • 13.2.1 KEYENCE CORPORATION
  • 13.2.2 CASSEL MESSTECHNIK GMBH
  • 13.2.3 THERMO FISHER SCIENTIFIC INC.
  • 13.2.4 LOMA SYSTEMS
  • 13.2.5 VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH
  • 13.2.6 MINEBEA INTEC GMBH
  • 13.2.7 MARCHESINI GROUP S.P.A.
  • 13.2.8 N.K.P. PHARMA PVT. LTD.
  • 13.2.9 SPAN SYSTEMS

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS